(Page 18 of 24)
|NEXT IMAGE >>|
|Reinventing Biotech’s Business Model — Steve Tregay of Forma Therapeutics described how he scraped together some venture capital, bought some cheap used equipment, and managed to build one of the most prolific drug discovery shops in the pharma industry, when so many other companies are avoiding investments in infrastructure. He’s done it on just $33 million in venture capital, and a lot more from its network of drug company partners.|
|Photo by Curt Woodward|
By posting a comment, you agree to our terms and conditions.